Patents Assigned to McGill University
-
Patent number: 11116665Abstract: Active dichoptic perceptual-learning tasks or dichoptic game play have been shown to significantly improve visual acuity of amblyopic children and adults. However, these dichoptic perceptual learning tasks are intensive and repetitive such that non-compliance is high. In contrast, the invention provides dichoptic perceptual learning in a manner that the user maintains its use and compliance is increased. Further, compliance becomes automatic if the user performs tasks in a normal manner and “forgets” that they are actually undergoing treatment as it is integrated with minimal disruption to their life and activities. Accordingly, a methodology exploiting complementary dichoptic simulation is presented.Type: GrantFiled: January 14, 2020Date of Patent: September 14, 2021Assignee: The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Robert F. Hess, Reza Farivar-Mohseni, Alexandre Reynaud
-
Patent number: 11117932Abstract: Aberrant cross talk between Notch ligand (e.g. Jag1) and Notch receptor (e.g. Notch1) has been implicated in tumorigenesis in the colon. Inhibition of Notch pathway is therefore an attractive approach for treating diseases with upregulated Jag1 e.g. colorectal cancer (CRC). Pan-notch inhibitors like gamma secretase inhibitors (GSIs) have been developed to inhibit Notch and its downstream events. However, severe gastrointestinal toxicity profiles impede the clinical development of GSIs. The present invention develops novel oligopeptides that specifically inhibit Jag1-Notch1 pathway without interfering DLL1-Notch1 or DLL4-Notch1, which demonstrates a clear advantage over pan-notch inhibitors.Type: GrantFiled: July 19, 2019Date of Patent: September 14, 2021Assignees: The Hong Kong Polytechnic University, The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Xuezhen Zhu, Yu-Wai Chen, Tak Hang William Chan, Ming Cheung Chow
-
Patent number: 11057053Abstract: Systems and methods of communicating using asymmetric polar codes are provided which overcome the codeword length constraints of systems and methods of communicating that use traditional polar codes. Used herein, asymmetric polar codes refers to a polarizing linear block code of any arbitrary length that is constructed by connecting together constituent polar codes of unequal length. Asymmetric polar codes may be known by other names. In comparison to conventional solutions for variable codeword length, asymmetric polar codes may provide more flexibility, improved performance, and/or reduced complexity of decoding, encoding, or code design. The system and method provide a flexible, universal, and well-defined coding scheme and to provide sound bit-error correction performance and low decoding latency (compared with current length-compatible methods which can be used with current hardware designs).Type: GrantFiled: September 13, 2019Date of Patent: July 6, 2021Assignees: Huawei Technologies Co., Ltd., The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Warren Jeffrey Gross, Adam Christian Cavatassi, Thibaud Tonnellier, Yiqun Ge
-
Patent number: 11014948Abstract: The invention relates to the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. In another aspect, the invention relates to compounds of formula (II): processes for making these compounds, and the use thereof in the chemical synthesis of oligonucleotides, e.g., oligoribonucleotides. The invention also relates to methods of synthesis of oligomers, including but not limited to oligopeptides, oligosaccharides and oligonucleotides, particularly oligoribonucleotides and also oligodeoxyribonucleotides, in solution systems, and ionic tag linkers for use in methods provided herein.Type: GrantFiled: March 19, 2018Date of Patent: May 25, 2021Assignees: The Royal Institution for the Advancement of Learning/McGill University, Hong Kong Polytechnic UniversityInventors: Masad J. Damha, Matthew Hassler, Tak-Hang Chan, Mallikarjuna Reddy Nandyala, Robert Alexander Donga
-
Patent number: 10954194Abstract: The invention relates to a method of treating a subject who has cancer or a non-malignant tumor, the method comprising administering a therapeutically effective amount of a 18-20 member bi-polycyclic compound to the subject.Type: GrantFiled: July 3, 2019Date of Patent: March 23, 2021Assignees: Haro Pharmaceuticals Inc., The Royal Institution for the Advancement of Learning/ McGill University, Universite De MontrealInventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
-
Patent number: 10905749Abstract: The present disclosure relates to methods of treating or preventing a biofilm-related infection and methods of preventing and treating biofilm formation on indwelling medical devices, implants, and non-medical surfaces comprising administering at least one soluble microbial protein that is encoded by an exopolysaccharide biosynthetic operon or functional gene cluster, wherein the protein comprises a glycosyl hydrolase domain. The present disclosure further provides particular soluble glycosyl hydrolases and compositions thereof.Type: GrantFiled: June 5, 2015Date of Patent: February 2, 2021Assignees: The Hospital for Sick Children, The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Lynne Howell, Perrin Baker, Noor Alnabelseya, Natalie Bamford, Dustin Little, Donald Sheppard, Brendan Snarr, Mark Jae Lee
-
Patent number: 10892379Abstract: GaN-based nanowire heterostructures have been intensively studied for applications in light emitting diodes (LEDs), lasers, solar cells and solar fuel devices. Surface charge properties play a dominant role on the device performance and have been addressed within the prior art by use of a relatively thick large bandgap AlGaN shell covering the surfaces of axial InGaN nanowire LED heterostructures has been explored and shown substantial promise in reducing surface recombination leading to improved carrier injection efficiency and output power. However, these lead to increased complexity in device design, growth and fabrication processes thereby reducing yield/performance and increasing costs for devices. Accordingly, there are taught self-organising InGaN/AlGaN core-shell quaternary nanowire heterostructures wherein the In-rich core and Al-rich shell spontaneously form during the growth process.Type: GrantFiled: November 26, 2019Date of Patent: January 12, 2021Assignee: The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Zetian Mi, Songrui Zhao, Renjie Wang
-
Patent number: 10752591Abstract: The invention relates to a method of inhibiting loss of muscle mass or muscle function in a subject in need thereof, or a method of treating miofibers ex vivo, the method comprising administering a therapeutically effective amount of a 18-20 member bi-polycyclic compound to the subject or to the miofibers.Type: GrantFiled: July 3, 2019Date of Patent: August 25, 2020Assignees: Haro Pharmaceuticals Inc., The Royal Institution for the Advancement of Learning/McGill University, Universite De MontrealInventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
-
Publication number: 20200238217Abstract: A technique for separating components of a microfluid, comprises a self-intersecting micro or nano-fluidic channel defining a cyclic path for circulating the fluid over a receiving surface of a fluid component separating member; and equipment for applying coordinated pressure to the channel at a plurality of pressure control areas along the cyclic path to circulate the fluid over the receiving surface, applying a pressure to encourage a desired transmission through the separating member, and a circulating pressure to remove surface obstructions on the separating member. The equipment preferably defines a peristaltic pump. Turbulent microfluidic flow appears to be produced.Type: ApplicationFiled: December 23, 2019Publication date: July 30, 2020Applicants: National Research Council of Canada, The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Kebin LI, Teodor VERES, Tohid Fatanat DIDAR, Maryam TABRIZIAN
-
Patent number: 10584159Abstract: Bioluminescence resonance energy transfer (BRET) biosensors for assessing the intracellular localization, internalization and trafficking into cellular compartments of proteins such as receptors, and other biomolecules such as second messengers, are disclosed. These biosensors, which are dependent on the concentration/density of the BRET donor and acceptor in cellular compartments rather that specific protein-protein interactions, use a Renilla GFP/Luc BRET pair, which allows the robust and reproducible monitoring of protein trafficking/localization, with a sensitivity compatible with high-throughput screening (HTS). The use of these biosensors for various applications, including assessing/monitoring protein endocytosis, recycling and intracellular trafficking, receptor maturation/rescue by pharmacological chaperones, various endocytosis/exocytosis processes, activation/inhibition, as well as biomolecule concentration/density in different cellular compartments, is also disclosed.Type: GrantFiled: September 21, 2015Date of Patent: March 10, 2020Assignees: The Royal Institution for the Advancement of Learning/McGill University, Université de MontréalInventors: Stéphane Alain Laporte, Yoon Namkung, Michel Bouvier, Christian Le Gouill, Mireille Hogue, Viktoriya Lukasheva, Hiroyuki Kobayashi, Denis Deblois, Étienne Durette
-
Patent number: 10569225Abstract: A technique for separating components of a microfluid, comprises a self-intersecting micro or nano-fluidic channel defining a cyclic path for circulating the fluid over a receiving surface of a fluid component separating member; and equipment for applying coordinated pressure to the channel at a plurality of pressure control areas along the cyclic path to circulate the fluid over the receiving surface, applying a pressure to encourage a desired transmission through the separating member, and a circulating pressure to remove surface obstructions on the separating member. The equipment preferably defines a peristaltic pump. Turbulent microfluidic flow appears to be produced.Type: GrantFiled: March 27, 2014Date of Patent: February 25, 2020Assignees: National Research Council of Canada, The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Kebin Li, Teodor Veres, Tohid Fatanat Didar, Maryam Tabrizian
-
Patent number: 10499822Abstract: Small implantable silicon-based devices offer an ability to revolutionize the management of trauma victims. For example, implantable pressure sensors allow the devastating outcomes of compartment syndrome to be minimized through continuous or periodic monitoring whilst being compatible with the ongoing drives to increase out-patient care and reduced hospitalization time. Further, small implantable silicon-based sensor microsystems according to embodiments of the invention whilst being capable of measuring pressures under diverse conditions are easily used by nurses in hospital settings as well as also being easily deployed by paramedical personnel in cases of accidents, natural disasters, war, etc. Beneficially, the implantable sensor microsystem will not interfere with movement of the patient during stabilization, surgery, intensive care stay, outpatient management, etc.Type: GrantFiled: May 8, 2015Date of Patent: December 10, 2019Assignee: The Royal Institution for the Advancement of Learning / McGill UniversityInventors: Edward Harvey, Vamsy Chodavarapu, Charles Allan
-
Patent number: 10420757Abstract: The current disclosure relates to methods for treating pancreatic cancer or chronic pancreatitis in a subject comprising administering an antagonist of a dopamine receptor to the subject wherein the dopamine receptor is, in some specific cases dopamine receptor D2 (DRD2). The antagonist in some specific cases is an RNAi construct, an antibody, or a small molecule and in more specific cases pimozide or L-741,626. The disclosure also relates to diagnostic methods comprising the detection of the expression of DRD2 in pancreatic tissue and kits for doing the same.Type: GrantFiled: April 17, 2015Date of Patent: September 24, 2019Assignees: Deutsches Krebsforschungszentrum Stiftung des Öffentlichenrechts, The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Pouria Jandaghi, Jörg Hoheisel, Yasser Riazalhosseini
-
Patent number: 10377715Abstract: The invention relates to 18-20 member bi-polycyclic compounds, methods of making these compounds, and methods of using them in treating hyperproliferative disorders (e.g., cancer) and non-malignant tumors; promoting muscle formation; inhibiting muscle degeneration or the loss of muscle mass or muscle function; and myofibers ex vivo.Type: GrantFiled: December 6, 2017Date of Patent: August 13, 2019Assignees: Haro Pharmaceuticals Inc., The Royal Institution for the Advancement of Learning/ McGill University, Universite De MontrealInventors: David Bettoun, Eduardo Martinez, James Gleason, Sylvie Mader, Shuo Xing
-
Publication number: 20190185844Abstract: The present disclosure provides CRISPR/Cas9 ribonucleoprotein compositions comprising chemically modified CRISPR RNA (crRNA) guide and trans-acting CRISPR RNA (tracrRNA) components. Methods of using the disclosed CRISPR/Cas9 ribonucleoprotein compositions are also provided.Type: ApplicationFiled: September 22, 2017Publication date: June 20, 2019Applicants: Board of Trustees of Southern lllinois University, The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Keith GAGNON, Masad DAMHA, Elise MALEK-ADAMIAN, Maryam HABIBIAN, Daniel O'REILLY, Zachery KARTJE
-
Patent number: 10287313Abstract: The present invention is directed to RNA monomers comprising O-acetal levulinyl protecting groups at the 2? and/or the 5?-hydroxy functionalities of the ribose moiety. Said monomers may be incorporated into oligoribonucleotides or RNA polynucleotides. Furthermore, the invention is directed to methods for the synthesis of said RNA monomers, oligoribonucleotides and RNA polynucleotides, as well as methods for their deprotection and methods for the use of said compounds and compositions comprising said compounds. In particular, such compounds and compositions comprising them are used in methods for light-directed synthesis of RNA microarrays.Type: GrantFiled: December 29, 2015Date of Patent: May 14, 2019Assignees: The Royal Institution for the Advancement of Learning/McGill University, Wisconsin Alumni Research FoundationInventors: Masad Damha, Jeremy Lackey, Debbie Mitra, Marvin Wickens, Franco Cerrina, Mark Somoza
-
Patent number: 10290767Abstract: GaN-based nanowire heterostructures have been intensively studied for applications in light emitting diodes (LEDs), lasers, solar cells and solar fuel devices. Surface charge properties play a dominant role on the device performance and have been addressed within the prior art by use of a relatively thick large bandgap AlGaN shell covering the surfaces of axial InGaN nanowire LED heterostructures has been explored and shown substantial promise in reducing surface recombination leading to improved carrier injection efficiency and output power. However, these lead to increased complexity in device design, growth and fabrication processes thereby reducing yield/performance and increasing costs for devices. Accordingly, there are taught self-organizing InGaN/AlGaN core-shell quaternary nanowire heterostructures wherein the In-rich core and Al-rich shell spontaneously form during the growth process.Type: GrantFiled: June 9, 2016Date of Patent: May 14, 2019Assignee: The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Zetian Mi, Songrui Zhao, Renjie Wang
-
Patent number: 10291200Abstract: MEMS based sensors, particularly capacitive sensors, potentially can address critical considerations for users including accuracy, repeatability, long-term stability, ease of calibration, resistance to chemical and physical contaminants, size, packaging, and cost effectiveness. Accordingly, it would be beneficial to exploit MEMS processes that allow for manufacturability and integration of resonator elements into cavities within the MEMS sensor that are at low pressure allowing high quality factor resonators and absolute pressure sensors to be implemented. Embodiments of the invention provide capacitive sensors and MEMS elements that can be implemented directly above silicon CMOS electronics.Type: GrantFiled: July 2, 2015Date of Patent: May 14, 2019Assignee: The Royal Institution for the Advancement of Learning / McGill UniversityInventors: Vamsy Chodavarapu, George Xereas
-
Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers
Patent number: 10208025Abstract: A triazole bridged flavonoid dimer compound library was efficiently constructed via the cycloaddition reaction of a series of flavonoid-containing azides (Az 1-15) and alkynes (Ac 1-17). These triazole bridged flavonoid dimers and their precursor alkyne- and azide-containing flavonoids were screened for their ability to modulate multidrug resistance (MDR) in P-gp-overexpressed cell line (LCC6MDR), MRP1-overexpressed cell line (2008/MRP1) and BCRP-overexpressed cell line (HEK293/R2 and MCF7-MX100). Generally, they displayed very promising MDR reversal activity against P-gp-, MRP1- and BCRP-mediated drug resistance. Moreover, they showed different levels of selectivity for various transporters. Overall, they can be divided into mono-selective, dual-selective and multi-selective modulators for the P-gp, MRP1 and BCRP transporters.Type: GrantFiled: October 18, 2016Date of Patent: February 19, 2019Assignees: The Hong Kong Polytechnic University, The Royal Institution for the Advancement of Learning/McGill UniversityInventors: Larry Ming Cheung Chow, Tak Hang Chan, Kin Fai Chan, Iris Lai King Wong, Man Chun Law -
Publication number: 20190002282Abstract: A hydrogel comprising a colloidal suspension of MIXMIIYPZ two-dimensional nanocrystals in water, wherein MI is Na+ and/or Li+, MII is Mg2+ or a mixture of Mg2+ with one or more Ni2+, Zn2+, Cu2+, Fe2+ and/or Mn2+, P is a mixture of dibasic phosphate ions (HPO42?) and tribasic phosphate ions (PO43?), X ranges from about 0.43 to about 0.63, Y ranges from about 0.10 to about 0.18, Z ranges from about 0.29 to about 0.48, X, Y, Z being mole fractions, is provided.Type: ApplicationFiled: December 2, 2016Publication date: January 3, 2019Applicant: The Royal Institute for the Advancement of Learning/McGill UniversityInventors: Faleh TAMIMI MARINO, Ashwaq Ali AL-HASHEDI, Marco LAURENTI, Ahmed Ebraheem AL SUBAIE, Mohamed-Nur ABDALLAH, Iskandar TAMIMI MARINO